RECRUITING

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

Talk to us

Conditions

Methamphetamine Use DisordersHIV

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic stimulation (TMS) paradigm that is efficient and potent.

Official Title

TMS (Transcranial Magnetic Stimulation) for Methamphetamine Use Disorder in People Living With HIV

Quick Facts

Study Start:2025-02-20
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06830980

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults in the age group 18-65 years
  2. * Able to read and understand English
  3. * Able to provide informed consent
  4. * Diagnosed with HIV
  5. * History of current or previous Methamphetamine Use Disorder
  6. * Endorse craving for methamphetamine
  7. * Demonstrate an attentional bias for methamphetamine
  1. * Traumatic brain injury
  2. * h/o seizure disorder
  3. * h/o or current diagnosis of schizophrenia
  4. * intracranial metal shrapnel
  5. * previous adverse effects with TMS
  6. * sub-threshold consistency while performing behavioral tasks
  7. * lack of attentional bias to methamphetamine cues
  8. * a positive pregnancy test for female participants

Contacts and Locations

Study Contact

Patricia Garth, CRC
CONTACT
859-382-7611
psych_research@uky.edu, annette.garth@uky.edu
Natalya Means, CRC
CONTACT
859-382-7611
Natalya.means@uky.edu

Principal Investigator

Gopalkumar Rakesh, MD
PRINCIPAL_INVESTIGATOR
University of Kentucky

Study Locations (Sites)

UK Department of Psychiatry
Lexington, Kentucky, 40509
United States
University of Kentucky Department of Psychiatry
Lexington, Kentucky, 40509
United States

Collaborators and Investigators

Sponsor: Gopalkumar Rakesh

  • Gopalkumar Rakesh, MD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-20
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2025-02-20
Study Completion Date2026-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Methamphetamine Use Disorders
  • HIV